The critical issue of hepatocellular carcinoma prognostic classification: Which is the best tool available?

Journal of Hepatology

Volumn 40, Issue 1, 2004, Pages 124-131

  Cillo, Umberto ^a   Bassanello, Marco ^a   Vitale, Alessandro ^a   Grigoletto, Francesco A ^a   Burra, Patrizia ^a   Fagiuoli, Stefano ^a   D'Amico, Francesco ^a   Ciarleglio, Francesco Antonio ^a   Boccagni, Patrizia ^a   Brolese, Alberto ^a   Zanus, Giacomo ^a   D'Amico, Davide Francesco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Hepatocellular carcinoma; Liver function; Prognosis; Staging; Therapeutic decision; Tumor stage

Indexed keywords

ADULT; AGED; ANALYTICAL EQUIPMENT; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; SURVIVAL TIME;

EID: 0347320500     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2003.09.027     Document Type: Article

References (32)

1. Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002;122:1609-1619.
2. Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Eng J Med 1991;325:675-680.
3. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340: 745-750.
4. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding esophageal varices. Br J Surg 1973;60:646-664.
5. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al. AJCC cancer staging manual. Philadelphia: Lippincott-Raven; 1997.
6. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M. AJCC cancer staging manual, 6th ed. Springer-Verlag; 2002. pp. 131-139.
7. Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994;106:720-727.
8. Johnson P, Bruix J. Hepatocellular carcinoma and the art of prognostication. J Hepatol 2000;33:1006-1008.
9. Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, et al. Surveillance program of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost-effectiveness analysis. Gut 2001;48:251-259.
10. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002;35:519-524.
11. Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati PL, Pigato P. Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer 1998;82:1028-1036.
12. Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991;214:221-228.
13. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334: 693-699.
14. Okuda K, Othtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 1985;56:918-928.
15. Levy I, Sherman M. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 2002;50:881-885.
16. The Cancer of the Liver Italian Program (CLIP) investigators, A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 1998;28:751-755.
17. Chevret S, Trinchet JC, Mathieu D, Rached AA, Beaugrand M, Chastang C. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. J Hepatol 1999;31:133-141.
18. Leung TW, Tang AM, Zee B, Lau WY, Lai PB, Leung KL, et al. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system. Cancer 2002;94:1760-1769.
19. [ 19] Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329-338.
20. Llovet JM, Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol 2003;38:S136-S149.
21. Ueno S, Tanabe G, Sako K, Hiwaki T, Hokotake H, Fukukura Y, et al. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology 2001;34:529-534.
22. Piscaglia F, Donati G, Serra C, Muratori R, Solmi L, Gaiani S, et al. Value of splanchnic doppler ultrasound in the diagnosis of portal hypertension. Ultrasound Med Biol 2001;27:893-899.
23. Stone M. Akaike's criteria. In: Armitage P, Colton T, editors. Encyclopedia of biostatistics. Chichester: Wiley; 1998. p. 123-124.
24. Feinsten AR. Clinical biostatistics XVI. The process of prognostic stratification. Clin Pharmacol Ther 1972;13:609-624.
25. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusion of the Barcelona - 2000 EASL Conference. J Hepatol 2001;35:421-430.
26. Orlandi F, Christensen E. A consensus conference on prognostic studies in Hepatology. J Hepatol 1999;30:171-172.
27. The Cancer of the Liver Italian Program (CLIP) Investigators, Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000;31:840-845.
28. Farinati F, Rinaldi M, Gianni S, Naccarato R. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer 2000;89:2266-2273.
29. Llovet JM, Bruix J. Letter to the editor. Hepatology 2000;32: 679-680.
30. Bruix J, Castells A, Bosh J, Feu F, Fuster J, Garcia-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996;111:1018.
31. Llovet JM, Bustamante J, Castells A, Villana R, Ayuso MC, Sala M, et al. Natural history of untreated non-surgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 1999;29:62-67.
32. Llovet JM, Real ME, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734-1739.